The identification of a mechanism of pathogenesis for DYSFPMMs is likely to aid clinicians in the diagnosis of individuals with dysferlinopathy through the (re)classification of known DYSF missense variants as pathogenic. This evidence concerns the gene DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.